HDAC6-IN-49
HDAC6-IN-49 (Compound 3) is an inhibitor for HDAC with IC50 of 0.012 and 0.735 μM for HDAC6 and HDAC1. HDAC6-IN-49 also exhibits inhibitory activities against MAO-B, cholinesterase (ChE), histamine receptor (H3R) and serotonin 6 receptor (5-HT6R) . HDAC6-IN-49 exhibits neuroprotective efficacy on SH-SY5Y cell. HDAC6-IN-49 improves cognitive function and locomotor ability in Drosophila Parkinson's disease models and in C. elegans Alzheimer's disease models[1].
Product Specifications
UNSPSC
12352005
Target
5-HT Receptor; Cholinesterase (ChE) ; HDAC; Histamine Receptor; Monoamine Oxidase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/hdac6-in-49.html
Smiles
O=S(N1C2=CC=C(C=C2C=C1)OCCCN3CCCCC3)(C4=CC=C(C=C4)C(NO)=O)=O
Molecular Formula
C23H27N3O5S
Molecular Weight
457.54
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC6
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Coelenterazine, 2-methyl derivative (Methyl coelenterazine)
Renal Cell Carcinoma (Carbonic Anhydrase IX) (66.4.C2), CF568 conjugate, 0.1mg/mL
